Literature DB >> 18508676

Of alphas and betas: distinct and overlapping functions of STAT3 isoforms.

Sarah Dewilde1, Alessandro Vercelli, Roberto Chiarle, Valeria Poli.   

Abstract

STAT3 is a pleiotropic factor activated by many different signals including cytokines, growth factors and oncogenes. It is involved in a striking number of functions and can activate distinct repertoires of genes in different contexts. Like other STAT factors, STAT3 exists in two isoforms generated by alternative splicing, the full length STAT3alpha and the truncated STAT3beta, generally thought to act as a dominant negative factor. However, STAT3beta is not transcriptionally inactive and is able to both activate and repress genes depending on cellular environment. These unique properties of the STAT3beta isoform may contribute to the extraordinary functional complexity of STAT3 physiological and pathological actions, revealed by conditional mutagenesis studies and not yet fully understood. With this in mind, we try here to summarize what is known about the structure and function of the alpha and beta STAT3 isoforms, both in vitro and in vivo. In addition, we report unpublished data describing the phenotype of mice where the STAT3alpha isoform was specifically ablated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508676     DOI: 10.2741/3170

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  17 in total

1.  Axonal transcription factors signal retrogradely in lesioned peripheral nerve.

Authors:  Keren Ben-Yaakov; Shachar Y Dagan; Yael Segal-Ruder; Ophir Shalem; Deepika Vuppalanchi; Dianna E Willis; Dmitry Yudin; Ida Rishal; Franziska Rother; Michael Bader; Armin Blesch; Yitzhak Pilpel; Jeffery L Twiss; Mike Fainzilber
Journal:  EMBO J       Date:  2012-01-13       Impact factor: 11.598

2.  Antitumorigenic potential of STAT3 alternative splicing modulation.

Authors:  Francesca Zammarchi; Elisa de Stanchina; Eirini Bournazou; Teerawit Supakorndej; Kathryn Martires; Elyn Riedel; Adriana D Corben; Jacqueline F Bromberg; Luca Cartegni
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

3.  Prevention of trauma/hemorrhagic shock-induced lung apoptosis by IL-6-mediated activation of Stat3.

Authors:  Ana Moran; Anna I Tsimelzon; Mary-Ann A Mastrangelo; Yong Wu; Bi Yu; Susan G Hilsenbeck; Valeria Poli; David J Tweardy
Journal:  Clin Transl Sci       Date:  2009-02       Impact factor: 4.689

Review 4.  STAT3 in hepatocellular carcinoma: new perspectives.

Authors:  Jasmin Svinka; Wolfgang Mikulits; Robert Eferl
Journal:  Hepat Oncol       Date:  2013-12-20

5.  Antisense Modulation of RNA Processing as a Therapeutic Approach in Cancer Therapy.

Authors:  Lee Spraggon; Luca Cartegni
Journal:  Drug Discov Today Ther Strateg       Date:  2013

Review 6.  STATus and Context within the Mammalian Nervous System.

Authors:  Prithi Rajan
Journal:  Mol Med       Date:  2011-05-20       Impact factor: 6.354

7.  Defective leukocyte GM-CSF receptor (CD116) expression and function in inflammatory bowel disease.

Authors:  Jonathan I Goldstein; Douglas J Kominsky; Nicole Jacobson; Brittelle Bowers; Kirsten Regalia; Gregory L Austin; Melinda Yousefi; Michael T Falta; Andrew P Fontenot; Mark E Gerich; Lucy Golden-Mason; Sean P Colgan
Journal:  Gastroenterology       Date:  2011-04-07       Impact factor: 22.682

8.  STAT3β is a tumor suppressor in acute myeloid leukemia.

Authors:  Petra Aigner; Tatsuaki Mizutani; Jaqueline Horvath; Thomas Eder; Stefan Heber; Karin Lind; Valentin Just; Herwig P Moll; Assa Yeroslaviz; Michael J M Fischer; Lukas Kenner; Balázs Győrffy; Heinz Sill; Florian Grebien; Richard Moriggl; Emilio Casanova; Dagmar Stoiber
Journal:  Blood Adv       Date:  2019-07-09

Review 9.  The Ying and Yang of STAT3 in Human Disease.

Authors:  Tiphanie P Vogel; Joshua D Milner; Megan A Cooper
Journal:  J Clin Immunol       Date:  2015-08-18       Impact factor: 8.317

10.  Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling.

Authors:  Pamina Pflegerl; Paul Vesely; Brigitte Hantusch; Michaela Schlederer; Rainer Zenz; Elke Janig; Günter Steiner; Arabella Meixner; Peter Petzelbauer; Peter Wolf; Afschin Soleiman; Gerda Egger; Richard Moriggl; Tadamitsu Kishimoto; Erwin F Wagner; Lukas Kenner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.